Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our lung transplant and lung cancer programs are leading the nation in discoveries of new treatments and development of new procedures, and our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. The Pulmonology, Critical Care and Sleep Medicine Division at The Mount Sinai Hospital is ranked No. 12 in the nation by U.S. News & World Report® for 2023-24.
Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our lung transplant and lung cancer programs are leading the nation in discoveries of new treatments and development of new procedures, and our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. The Pulmonology, Critical Care and Sleep Medicine Division at The Mount Sinai Hospital is ranked No. 12 in the nation by U.S. News & World Report® for 2023-24.
Mount Sinai’s Scott Scheinin, MD, and Harish Seethamraju, MD, are establishing the End-Stage Lung Disease and Transplant Program as a leader in treating complex cases.
Mount Sinai researchers have developed a novel, automated measure of analyzing sleep studies to determine the severity and risk of mortality in patients with obstructive sleep apnea, a chronic sleep disorder that affects about 30 million ...
The Mount Sinai Respiratory Institutes is offering a 2 day comprehensive course on advanced topics in pulmonary medicine, directed toward community pulmonologists, advanced practice NP and PA providers as well primary care physicians.
Influenza infection (flu) is a major cause of death around the world, especially during years of flu pandemics. People who die of the flu often have a secondary lung infection with Staphylococcus aureus (staph) bacteria that starts a few ...
Mount Sinai Health System is using custom 3D-printed stents to open the trachea and main bronchi of patients with complex airway anatomy. Over time, an interventional pulmonologist believes, they could replace standard stenting for benign ...
A new Mount Sinai research program aims to map the developing pediatric airway from minimally invasive respiratory samples obtained during flexible bronchoscopy, with the goal of advancing cystic fibrosis therapeutics and enabling the ...
A first-of-its-kind study led by a Mount Sinai researcher suggests that even a brief withdrawal of continuous positive airway pressure therapy for sleep apnea might increase one’s risk of developing Alzheimer’s disease.
Mount Sinai has launched a novel technology-driven teaching scholars curriculum that uses a blended learning model to prepare subspecialty pulmonary and critical care fellows for careers as clinician-educators.
Mount Sinai is undertaking several initiatives to better understand the factors that contribute to severe asthma and identify different subtypes of the disease. The work is intended to bring a precision medicine approach to asthma.
A Mount Sinai physician has developed an algorithm that uses a range of electronic medical record data to identify patients who are ready to be liberated from ventilation.
The Mount Sinai – National Jewish Health Respiratory Institute’s Pleural Service, launched in 2020, has used pleuroscopy to dramatically increase its reach and the number and acuity of patients it can serve.
Mount Sinai's exercise physiology program, which went dormant during the COVID-19 pandemic, has been revitalized with a new leader, sleek state-of-the-art hardware, software upgrades, and more.
Mount Sinai's medical intensive care unit is adjusting to the "new normal" post-pandemic by ensuring that its teams have the tools to manage future crises.
This study provides one of the most comprehensive analyses of interstitial lung disease diagnosis and treatment in patients who received an antibody drug conjugate known as T-DXd, from a class of drugs designed as a targeted therapy for treating cancers.
Mount Sinai Health System, Jefferson Health, and National Jewish Health have begun working together to advance understanding, diagnosis, and treatment of a range of pulmonary diseases, some of which have traditionally been orphan diseases.
The Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, like the entire Mount Sinai Health System, is making concerted efforts to become an anti-racist institution.
The multidisciplinary Chronic Lung Care Program at Mount Sinai Kravis Children’s Hospital was established to help care for infants in the NICU with evolving and established chronic respiratory failure.
Gene signatures derived from lung carcinoma could potentially predict outcomes among individuals with small lung cancers detected by chest CT imaging, when those tumors cannot be distinguished visually as aggressive or indolent.
Fewer than 10 percent of potentially eligible patients undergo lung cancer screening, resulting in unnecessary illness and death. The new Chief of Pulmonary, Critical Care and Sleep Medicine at Mount Sinai Morningside wants to change that.
Mount Sinai will serve as a hub site for two cohort studies as part of the NIH Researching COVID to Enhance Recovery (RECOVER) Initiative, which will assess the post-acute sequelae of SARS-CoV-2 infection (PASC).
Mount Sinai Health System has recruited two world-renowned experts to establish a lung transplantation program that will care for both traditional and highly complex cases. The demand for these services is projected to grow as more patients ...
From addressing the aftermath of COVID-19 to stepping up the fight against lung cancer, Mount Sinai’s Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine continues to move the field forward.
The Institute for Airway Science (IAS) is comprised of translational and basic scientists with expertise in the areas of epithelial science, stem cell science, and transplant immunology.
From addressing the aftermath of COVID-19 to stepping up the fight against lung cancer, Mount Sinai’s Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine continues to move the field forward.
Charles Powell, MD, System Chief for Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine and CEO of the Mount Sinai-National Jewish Health Respiratory Institute, answers questions regarding anti-HER2 monoclonal ...
Even before the first patient arrived at our doors, a Mount Sinai research team working with CT scans from patients in China noticed that this disease did not look like a normal pneumonia.
